Biocon Ltd. — Regulatory Filings 2022

Jul 5, 2022

==> picture [132 x 52] intentionally omitted <==

Biocon Limited 20th KM, Hosur Road Electronic City Bangalore 560 100, India T 91 80 2808 2808 F 91 80 2852 3423 CIN : L24234KA1978PLC003417

www.biocon.com

July 5, 2022

ToThe Manager,BSE LimitedDepartment of Corporate ServicesPhiroze Jeejeebhoy Towers,Dalal Street,Mumbai – 400 001	ToThe Manager,National Stock Exchange of India LimitedCorporate Communication DepartmentExchange Plaza, Bandra Kurla ComplexMumbai – 400 050
Scrip Code - 532523	Scrip Symbol - Biocon

Subject: Company Statement

Dear Sir/Madam,

Please find enclosed a Company Statement titled “Biocon Biologics Receives EU GMP Certification for Its New Biologics Manufacturing Facility in Bengaluru”.

The above information will also be available on the website of the Company at www.biocon.com.

Kindly take the same on record and acknowledge.

Thanking You,

Yours faithfully,

For Biocon Limited

==> picture [99 x 32] intentionally omitted <==

_______________ Mayank Verma Company Secretary and Compliance Officer

==> picture [81 x 36] intentionally omitted <==

==> picture [140 x 32] intentionally omitted <==

NOTIFICATION TO STOCK EXCHANGE

COMPANY STATEMENT

Biocon Biologics Receives EU GMP Certification for Its New Biologics Manufacturing Facility in Bengaluru

Bengaluru, India; July 5, 2022:

“Biocon Biologics Ltd., a subsidiary of Biocon Ltd. (BSE code: 532523, NSE: BIOCON), has received a EU GMP certificate from the Health Products Regulatory Authority (HPRA), Ireland, for its new monoclonal antibodies (mAbs) drug substance manufacturing facility (B3) at Biocon Park, Bengaluru, following a GMP inspection in April 2022.

The facility, spread across 340,000-square feet, will enhance our capabilities manifold to manufacture drug substance of our mAbs portfolio and will enable us to serve patients across the globe. This integrated, multi-product facility houses manufacturing suites, analytical testing laboratories and warehousing. Upon successful completion and qualification in 2021, it was awarded the Facility of the Year Award (FOYA) with a Honorable Mention, by the International Society for Pharmaceutical Engineering’s (ISPE).”

-- Company Spokesperson, Biocon Biologics.

For more information seema.ahuja@biocon.com +919972317792

1